Clinical Trials Logo

Filter by:
NCT ID: NCT01374906 Completed - Cushing's Disease Clinical Trials

Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease

Start date: November 4, 2011
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, multicenter, phase III study to evaluate the safety and efficacy of 2 dosing regiments of Pasireotide long acting release (LAR) in patients with Cushing's disease.

NCT ID: NCT01374451 Completed - Islet Cell Tumor Clinical Trials

Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET

COOPERATE-1
Start date: June 2011
Phase: Phase 2
Study type: Interventional

This study will estimate the treatment effect of everolimus in combination with pasireotide LAR relative to everolimus alone on progression-free survival (PFS) in patients with advanced progressive PNET

NCT ID: NCT01374152 Completed - Stroke Clinical Trials

Perfetti Method in Upper Extremity of Stroke Patients

Start date: July 2008
Phase: Phase 3
Study type: Interventional

The cognitive sensory motor training therapy (Perfetti's technique) might be more effectiveness than conventional occupational therapy on upper extremity function recovery after acute stroke patients.

NCT ID: NCT01373775 Completed - Clinical trials for Congestive Heart Failure

Risk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department Siriraj Hospital

Start date: April 2009
Phase: N/A
Study type: Observational

To identify the risk factors of the revisit of the adult HF patients in emergency department.

NCT ID: NCT01373437 Completed - Clinical trials for Endotracheal Tube Wrongly Placed During Anesthetic Procedure

Ultrasonography in Confirming Proper Position of Endotracheal Tube

Start date: September 2010
Phase: N/A
Study type: Observational

The purpose of this study is to assess the applicability of using ultrasonography in confirmation of the position of the endotracheal tube (ETT) after intubated to patients.

NCT ID: NCT01373281 Completed - Dengue Clinical Trials

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia

Start date: June 3, 2011
Phase: Phase 3
Study type: Interventional

The aim of the trial was to assess the efficacy of the CYD dengue vaccine in preventing symptomatic, virologically-confirmed dengue (VCD) cases. Primary Objective: To assess the efficacy of CYD dengue vaccine after 3 vaccinations at 0, 6, and 12 months in preventing symptomatic VCD cases, regardless of the severity, due to any of the four serotypes in children aged 2 to 14 years at the time of inclusion. Secondary Objectives: - To describe the efficacy of CYD dengue vaccine in preventing symptomatic VCD cases after the third dose to the end of the Active Phase, after at least 1 dose, and after 2 doses. - To describe the occurrence of serious adverse events (SAEs), including SAEs of special interest in all participants throughout the trial period. - To describe the occurrence of hospitalized virologically-confirmed dengue (VCD) cases and the occurrence of severe (clinically-severe or as per World Health Organization (WHO) criteria) VCD cases, throughout the Surveillance Expansion period (SEP) and throughout the trial (from Day 0 to the end of the study). - To describe the antibody response to each dengue serotype after Dose 2, after Dose 3, and 1 and 5 years after Dose 3.

NCT ID: NCT01365507 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens

BOOSTâ„¢
Start date: June 2011
Phase: Phase 3
Study type: Interventional

This trial is conducted in Asia and North America. The aim of this trial is to compare the efficacy and safety of insulin degludec/insulin aspart (IDegAsp) once daily in insulin-naïve subjects with type 2 diabetes mellitus when using two different titration algorithms (dose individually adjusted) as add-on to subject's ongoing treatment with metformin.

NCT ID: NCT01364194 Completed - Pain, Postoperative Clinical Trials

Local Infiltration With Bupivacaine to Increase Quality of Post-operative Pain Control in Total Knee Replacement

Start date: March 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy of periarticular injection with 0.25% bupivacaine for controlling pain after total knee replacement to improve the quality of post-operative care.

NCT ID: NCT01363869 Completed - Gout Clinical Trials

Effects of Green Tea on Level of Serum Uric Acid in Healthy Individuals

Start date: June 2011
Phase: N/A
Study type: Interventional

Green tea has been extensively investigated for several potential health benefits. Previous studies have suggested that green tea may lower serum uric acid level in human. The purpose of this study is to investigate uric-lowering properties of green tea in healthy individuals.

NCT ID: NCT01363414 Completed - Dry Eye Clinical Trials

Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes

Start date: January 2007
Phase: N/A
Study type: Interventional

Eyes with abnormal tear film function have been found to show larger optical aberrations than normal eyes which may be attributed to the unstable and irregular tear film, uneven ocular surface, and increased scatter due to the exposure of the rough surface of corneal epithelium after tear break-up. These hypotheses have been supported by the findings that instillation of artificial tears (sodium hyaluronate preparation) in dry eye patients reduces both corneal and ocular aberrations, improving the optical quality of the retinal image. However, the previous studies only evaluated the short-term effects of a single administration of an artificial tear but did not determine the duration of action or inflection point at which the ocular aberrations increase back to baseline. Also, there has clearly been no such clinical trial that has been a well randomized controlled study to date. This report is the first randomized controlled trial that investigated the long-term effects of a single dose of sodium hyaluronate-based artificial tears on wavefront aberrations in patients with dry eye.